Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Computer vision, generative AI, robotics to drive global AI revenue to $383 billion in 2030, forecasts GlobalData

AI revenue to reach $383 billion in 2030 Key drivers are the explosion in the volume of sensor data, advanced deep learning models, the emergence of generative AI, and the availability of AI chips. China’s AI growth will likely be hindered by limited access to advanced Western chip manufacturing technology and regulatory divergence The global […]
Read more

GlobalData reveals diverse perspectives among Twitter influencers around Meta Verified

Meta Platforms, Inc (Meta), the parent company of Facebook and Instagram, has launched a paid subscription bundle “Meta Verified” starting at $11.99 a month that includes account verification with impersonation protections and access to increased visibility and support. Following the announcement, diverse perspectives among the Twitter influencers around Meta surged dramatically in the third week […]
Read more

Energy transition drove 25% of the top 20 M&A deals in mining in 2022, says GlobalData

Energy transition was the key driver behind 25% of the top 20 mergers and acquisitions (M&A) deals in mining in 2022, as the industry responded to consumer and shareholder demand for portfolio diversification and sustainability, says GlobalData, a leading data and analytics company. Decarbonization efforts increased the demand for enabling metals GlobalData’s report ‘Mining Industry […]
Read more

Moderna’s non-vaccine mRNA therapeutic set to generate $278 million in 2028 if approved, estimates GlobalData

Moderna recently confirmed that its Phase I/II study examining candidate mRNA-3927 is progressing. It also shared that data showed a decrease in the number of metabolic decompensation events (MDEs) in trials of mRNA-3927, and regulators seemed to be supportive of MDE as a primary endpoint for the study. Additionally, Moderna stated that all eligible participants […]
Read more

Payment cards account for over half of e-commerce payments in Philippines, reveals GlobalData

Cards remain the most preferred payment tool for e-commerce purchases in the Philippines, accounting for over half of online purchases in 2022, finds GlobalData’s 2022 Financial Services Consumer Survey*. GlobalData’s E-Commerce Analytics reveal that the Philippines e-commerce market grew by an estimated rate of 31.3% in 2022 to reach PHP500.9 billion ($9.8 billion), as increasing […]
Read more

Growth, expansion and late-stage VC funding rounds in APAC down by 22.5% in 2022 while early-stage rounds see marginal growth, finds GlobalData

A total of 6,046 venture capital (VC) deals with disclosed funding rounds were announced in the Asia-Pacific (APAC) region in 2022, which is a decline of 6.8% over 2021. The decline was mainly driven by a massive 22.5% fall in announcement of growth, expansion and late-stage VC funding rounds (Series B onwards). Meanwhile, the number […]
Read more

Trodelvy set to become Gilead’s blockbuster with expanded approval, predicts GlobalData

The FDA recently granted expanded approval for Gilead Sciences’ Trodelvy (sacituzumab govitecan-hziy) for patients with HR-positive/HER2-negative metastatic breast cancer who have received hormonal therapy and at least two additional therapies in the metastatic setting. Trodelvy gained approval by outperforming traditional chemotherapies in this patient group. The drug is expected to become a standard of care […]
Read more

India’s HAL set to make a mark in foreign defense market with Tejas, says GlobalData

Following the news that India is in talks with Egyptian and Argentinian officials over a possible deal to supply 35 aircraft of Hindustan Aeronautics Limited’s (HAL) Tejas LCA Mk-1A; Chandan Kumar Nayak, Defense Analyst at GlobalData, a leading data and analytics company, offers his view: “GlobalData expects that the contracts will strengthen the domestic aerospace […]
Read more

Seasonal products will help Japanese PA&H insurers boost growth, says GlobalData

Japanese personal accident and health (PA&H) insurers have started offering insurance policies covering seasonal illnesses. Given a persistent decline in premiums due to challenging economic conditions, the move is expected to help the country’s PA&H insurance industry to boost revenue growth, says GlobalData, a leading data and analytics company. As per GlobalData’s insurance database, Japan’s […]
Read more

Clinical hold on 4D Molecular’s Fabry program to rise chances for Sangamo to lead FD gene therapy market, says GlobalData

4D Molecular Therapeutics (4DMT), the California-based biotechnology company focused on developing gene therapies for rare and cardiovascular, pulmonary, and ophthalmic diseases, has recently been issued a clinical hold by the FDA for its Fabry Disease (FD) gene therapy program (4D-310).  4DMT and Sangam Therapeutics are the leading developers in the Fabry disease space, and with […]
Read more

Asundexian phase III trial critical for Bayer to become market leader in anticoagulation to prevent stroke in AF patients, says GlobalData

Following the enrollment of the first patient in Bayer’s Phase III OCEANIC-AF clinical trial of asundexian, a potential anticoagulant for stroke prevention in atrial fibrillation (AF) patients; Amy Murray, Healthcare Analyst at GlobalData, a leading data and analytics company, offers her view: “Despite advances in anticoagulation therapy over the last decade, the increased risk and […]
Read more
1 … 122 123 124 125 126 … 136